School of Medicine


Showing 11-20 of 23 Results

  • Emily Charlson

    Emily Charlson

    Clinical Instructor, Ophthalmology

    Bio Emily Sarah Charlson, MD, PhD, is a Clinical Instructor of Ophthalmology and the Ophthalmic Plastic & Reconstructive Surgery, Orbital Oncology Fellow with the Byers Eye Institute. She completed her undergraduate degree in Honors Biology at Arizona State University. After discovering genetics research in Arizona, she pursued a combined Medical Scientist Training Program at the University of Pennsylvania with a PhD in Cellular and Molecular Biology. Her thesis centered on the Human Microbiome Project utilizing deep sequencing and bioinformatics to characterize the microbial communities that live on and in the human body in health and disease. After a transitional year internship at Santa Clara Valley Medical Center she completed her Ophthalmology residency with the Gavin Herbert Eye Institute at the University of California, Irvine before coming to Stanford as a Clinical Instructor of Ophthalmology and Oculoplastic and Orbital Oncology Fellow.

  • Fang Chen (Rosy)

    Fang Chen (Rosy)

    Postdoctoral Research Fellow, Ophthalmology

    Current Research and Scholarly Interests Corneal regeneration via hydrogel-based cell scaffold and cell encapsulation

  • Wei Chen

    Wei Chen

    Postdoctoral Research Fellow, Ophthalmology

    Bio My long-term goals involve the development of a full understanding of key molecular mechanisms and the identification of corresponding therapeutics for human diseases. My research training and academic experience have provided me with an excellent background necessary in multiple fields including molecular biology, cell biology, medicinal chemistry, and biochemical pharmacology. As an undergraduate, I have learned numerous biology and physiology courses, which let me appreciate and understand biological diversity. As a predoctoral student, my research focused on the identification and evaluation of fusion proteins, gene therapy-based biologics, molecular modifiers and inhibitors to treat tissue injury or cancer. We first revealed a novel mechanism underscoring the regulation of metabolic profiles and mitochondrial function of epithelial cells by IL-22 during cell injury, which might provide useful insights from the bench to the clinic in treating and preventing more diseases, especially acute stroke/traumatic brain injuries. We subsequently demonstrated that autophagy was induced to play cytoprotective roles in numerous cells, which highlighted the potential therapeutic strategies for CNS neurodegeneration diseases or cancer by targeting autophagy. During my undergraduate and graduate careers, I also received several academic awards, including two times National Scholarship. For my postdoctoral training, I will continue to build on my previous researches in metabolic profiles and mitochondrial function regulations by concentrating on determining the role of mitochondrial thioredoxin metabolism in neuronal survival. These new scientific issues will allow me to address additional problems regarding the molecular basis of neurodegeneration and develop a neuroprotective gene therapy strategy to protect CNS neurodegenerative diseases/injuries.

  • E.J. Chichilnisky

    E.J. Chichilnisky

    John R. Adler Professor, Professor of Neurosurgery and of Ophthalmology and, by courtesy, of Electrical Engineering

    Current Research and Scholarly Interests Functional circuitry of the retina and design of retinal prostheses

Footer Links:

Stanford Medicine Resources: